Latest updates for Fbrx

Fresh curated links around FBRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Forte Biosciences: FB102 Is Becoming A Platform Story, Not A Single-Indication Bet
  • BridgeBio: "Strong Buy" Attruby Differentiation And Several NDA Submissions In Play
  • ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /6 days ago

Forte Biosciences: FB102 Is Becoming A Platform Story, Not A Single-Indication Bet

Read source
seekingalpha.com /3 days ago

BridgeBio: "Strong Buy" Attruby Differentiation And Several NDA Submissions In Play

Read source
seekingalpha.com /1 month ago

ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout

Read source
seekingalpha.com /1 month ago

Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg...

Read source
qchron.com /1 month ago

BIFOX ENTERS INTO AGREEMENTS TO ACQUIRE THE 550 MILLION TONNE[1] BAYOVAR 9 PHOSPHATE ROCK PROJECT IN PERU POSITIONING BI...

SYDNEY, June 15, 2026 /PRNewswire/ -- Bifox Limited ("Bifox") is pleased to advise it has entered into two agreements with Fossal S.A.A ("Fossal"), to purchase all of the shares of...

Read source
seekingalpha.com /1 month ago

Brixmor Property Group Inc. (BRX) Shareholder/Analyst Call Transcript

Read source
seekingalpha.com /1 week ago

Travere Therapeutics: Filspari Is Becoming A Rare Kidney Disease Platform

Read source
cafepharma.com /1 month ago

SFM

SFM Anonymous (not verified) Wed, 06/10/2026 - 20:50 field_thread_url https://cafepharma.com/boards/threads/sfm.701491/ board name...

Read source
cafepharma.com /6 days ago

BridgeBio

BridgeBio Anonymous (not verified) Thu, 07/09/2026 - 09:10 field_thread_url https://cafepharma.com/boards/threads/bridgebio.698762/ boar...

Read source
orthotw.com /3 weeks ago

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Bi...

BioRestorative Therapies, Inc. today announced the successful completion of manufacturing for its BRTX-100 Phase 2 clinical trial.

Read source
cafepharma.com /1 month ago

SFM

SFM Anonymous (not verified) Sun, 06/14/2026 - 20:54 field_thread_url https://cafepharma.com/boards/threads/sfm.701491/ board name...

Read source
prweb.com /3 days ago

FACTOR X Emerges from Stealth with Novel RNA - based Technology to Transform the Global Beauty Industry

FACTOR X is a newly launched longevity-focused beauty technology company developing a breakthrough cellular delivery platform designed to transform the anti-aging skincare industry...

Read source
seekingalpha.com /1 month ago

Freedom Holding launches up to $300M stock offering

Read source
seekingalpha.com /2 weeks ago

Franklin BSP Realty Trust Preferred: A High-Yield Allocation For An Elevated-Rate Environment

Read source
seekingalpha.com /3 weeks ago

L.B. Foster Company (FSTR) Presents at Sidoti Small-Cap Virtual Investor Conference - Slideshow

Read source
finance.yahoo.com /3 weeks ago

Is BellRing Brands, Inc. (BRBR) A Good Stock To Buy Now?

Read source
fool.com /1 month ago

RXO Stock Has Surged 75% Since This Fund Made a $10 Million Bet

RXO uses a digital freight marketplace to deliver asset-light logistics and transportation solutions across multiple U.S. industries.

Read source
seekingalpha.com /1 day ago

Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin

Read source
seekingalpha.com /1 month ago

The Prognosis For Palvella Therapeutics

Read source
seekingalpha.com /3 weeks ago

Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission

Read source
seekingalpha.com /1 month ago

Freshpet, Inc. (FRPT) Presents at 23rd annual dbAccess Global Consumer Conference - Slideshow

Read source
seekingalpha.com /1 month ago

SAB Biotherapeutics, Inc. (SABS) Presents at FOCIS 2026 Annual Meeting - Slideshow

Read source
seekingalpha.com /2 weeks ago

Fermi: Hyper High Risk, Hyper High Reward

Read source
seekingalpha.com /3 weeks ago

Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Fbrx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

ryortho.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source